Type II variation for application HSA-2023-0052. Type II variation: Shelf Life Extension for Verasenib — major revision

Variation Number
HSA-2023-0052-V452
Type
Type II
Application
Status
In Progress
Fee
€30,991
Submitted
2023-06-03
Approved
—
Description

Type II variation: Shelf Life Extension for Verasenib — major revision